Pharma Journalist -

AstraZeneca’s Forxiga (dapagliflozin) has been approved in China to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with heart failure…
Read More...

SMi Reports: The 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi) will take place for its 5th consecutive year as a virtual conference to explore…
Read More...

A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces the addition of Bruce Zhang, Director of…
Read More...

Johnson & Johnson announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for…
Read More...

TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group ("TCG"), has announced the expansion of its operations in the USA with the establishment of TCG…
Read More...

Tiziana Life Sciences plc a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the completion of its clinical study…
Read More...

GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19 with the…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced the Swiss Federal Government has increased its confirmed order commitment…
Read More...

Matrix Medical Network announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting…
Read More...

Bristol Myers Squibb and WuXi STA – a subsidiary of WuXi AppTec – announced that WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.…
Read More...